Development of Pain Related Avoidance of Movement Questionnaire

Sponsor
Hasan Kalyoncu University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05320679
Collaborator
(none)
400
1
8.9
44.8

Study Details

Study Description

Brief Summary

In recent studies, it has been shown that people may have avoidance of movement due to pain. However, there is no scale that evaluates avoidance of movement due to pain in musculoskeletal problems. The aim of this study is to develop a scale to measure how much pain-related movement and activity is avoided in individuals with musculoskeletal pain, and to examine the results of its clinical application.

Condition or Disease Intervention/Treatment Phase
  • Other: Implementation of Questionnaire

Detailed Description

Approaches and methods to be applied in the research;

  • Demographic information (age, gender, weight, height, pain location, pain duration and diagnose) form will be recorded.

  • Creation of questionnaire items

  • Reviewing of items/questions

  • Patients who accept to fill out the questionnaire and who has complain of musculoskeletal pain will be asked to answer the questions.

  • Editing the scale according to the answers

  • Reliability and validity studies of the questionnaire

  • Investigation of the results of applying the scale with clinical follow-up

To compare results of Pain-Related Avoidance of Movement Questionnaire following common used questionnaires are going to be used;

  • Visual Analogue Scale (VAS)

  • Tampa Kinesiophobia Scale

  • Oswestry Low Back Pain and Disability Index-2.0

SPSS version 23 (SPSS Inc, Armonk, NY) program will be used in the analysis of the data.

Study Design

Study Type:
Observational
Anticipated Enrollment :
400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Development and Implementation of Pain Related Avoidance of Movement
Actual Study Start Date :
Apr 2, 2022
Anticipated Primary Completion Date :
Aug 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Study Group

Patients who have musculoskeletal pain

Other: Implementation of Questionnaire
Compartment of results of questionnaires which already been used in literature and results of developing Pain Related Avoidance of Movement Questionnaire

Outcome Measures

Primary Outcome Measures

  1. Total points of Pain Related Avoidance of Movement Questionnaire [1 week]

    Pain related avoidance of movement score is going to be assess by Pain Related Avoidance of Movement Questionnaire to determine change from baseline and, to examine correlation of other questionnaires.

Secondary Outcome Measures

  1. Change from baseline score in pain score [1 week]

    Pain score is going to be assess by VAS to determine change from baseline. Normal range of VAS score is between 0 point to 10 points. Higher score means worse pain level.

  2. Change from baseline score in kinesiophobia score [1 week]

    Kinesiophobia score is going to be assess by Tampa Kinesiophobia Scale to determine change from baseline. The normal range of kinesiophobia score is between 17 points to 68 points. Higher score means worse kinesiophobia level.

  3. Change from baseline in disability score [1 week]

    Disability score is going to be assess by Oswestry Disability Index to determine the change from baseline. The normal range of percentage is between 0 to 100. Higher percentage means worse disability level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria;

  • Having agreed to fill out the questionnaire

  • Having pain caused by problems related to the musculoskeletal system

  • Not having any disability in performing activities of daily living

Exclusion Criteria;

  • Individuals who are not allowed to move due to pain

  • If they have undergone surgery, individuals who have inconveniences in moving due to surgery

  • Individuals who have cognitive problems in completing the questionnaire

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hasan Kalyoncu University Gaziantep Turkey 27100

Sponsors and Collaborators

  • Hasan Kalyoncu University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yavuz Yakut, Professor, Hasan Kalyoncu University
ClinicalTrials.gov Identifier:
NCT05320679
Other Study ID Numbers:
  • 2020/021
First Posted:
Apr 11, 2022
Last Update Posted:
Apr 15, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yavuz Yakut, Professor, Hasan Kalyoncu University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2022